• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

PRESSLED

Your Leading News Source

PRESSLED
Your Leading News Source

  • Home
  • BUSINESS
  • MONEY
  • POLITICS
  • REAL ESTATE
  • US
  • Meet the Reporters
  • About/Contact

Tucson’s NuvOx adds plant to make drugs in-house | Business News

May 23, 2021 by Staff Reporter

NuvOx also is conducting preclinical studies using its drugs to treat traumatic brain injury, heart attack, shock induced by heavy bleeding and a common complication of sickle cell disease.

The COVID-19 pandemic also has made fundraising more difficult for the privately held company, Unger said.

The company is now looking to raise a bridge round of $3 million and will need $15 million to $20 million to finish the next rounds of clinical trials, he said.

“I think in order to ink the deal, you have to meet in person, and just now it’s opening up,” said Evan Unger, who has often crisscrossed the country for investor presentations.

Microvascular Therapeutics, with Wyatt Unger as chief medical officer, is working to develop an improved version of Definity, an ultrasound contrast agent the elder Unger developed in the 1990s and sold to chemicals giant DuPont in 1999 for about $40 million.

Definity, launched in 2001 and approved for ultrasound imaging of the heart, has since changed hands but is still the most prescribed drug of its kind in the U.S.

In 2018, Microvascular Therapeutics won a $1.7 million grant from the National Institutes of Health to develop its initial drug, called MVT-100.

The company is conducting a Phase I clinical trial to gauge the new contrast agent’s safety and effectiveness when used for echocardiograms — ultrasound imaging of the heart — compared with Definity.

Originally Appeared Here

Filed Under: BUSINESS

Primary Sidebar

More to See

Lone Star: Texas Tech Kicker Jonathan Garibay on Dallas Cowboys ‘Opportunity’

The Dallas Cowboys have a vacancy - and just one kicker presently on the roster. And he's a familiar face to Texas Tech fans, as it's Jonathan … [Read More...] about Lone Star: Texas Tech Kicker Jonathan Garibay on Dallas Cowboys ‘Opportunity’

Pan Asia Bank appoints Naleen Edirisinghe as COO – Financial News

Pan Asia Bank recently announced the appointment of Naleen Edirisinghe as its Chief Operating Officer (COO) with effect from 26th April 2022 to take … [Read More...] about Pan Asia Bank appoints Naleen Edirisinghe as COO – Financial News

CRE funds invest billions in U.S. real estate

Multiple commercial real estate funds have poured more than $2.5 billion into the U.S. real estate market in recent weeks, Bisnow reports. These CRE … [Read More...] about CRE funds invest billions in U.S. real estate

Privacy Policy | Terms and Conditions | About/ Contact
Copyright © 2022 · PRESSLED · As Amazon Associates we earn commissions from qualifying purchases · Log in

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT